These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 24061475)
1. Downregulation of PHLPP expression contributes to hypoxia-induced resistance to chemotherapy in colon cancer cells. Wen YA; Stevens PD; Gasser ML; Andrei R; Gao T Mol Cell Biol; 2013 Nov; 33(22):4594-605. PubMed ID: 24061475 [TBL] [Abstract][Full Text] [Related]
2. mTOR-dependent regulation of PHLPP expression controls the rapamycin sensitivity in cancer cells. Liu J; Stevens PD; Gao T J Biol Chem; 2011 Feb; 286(8):6510-20. PubMed ID: 21177869 [TBL] [Abstract][Full Text] [Related]
3. The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancer. Li X; Stevens PD; Yang H; Gulhati P; Wang W; Evers BM; Gao T Oncogene; 2013 Jan; 32(4):471-8. PubMed ID: 22391563 [TBL] [Abstract][Full Text] [Related]
4. Downregulation of PHLPP induced by endoplasmic reticulum stress promotes eIF2α phosphorylation and chemoresistance in colon cancer. Guo B; Xiong X; Hasani S; Wen YA; Li AT; Martinez R; Skaggs AT; Gao T Cell Death Dis; 2021 Oct; 12(11):960. PubMed ID: 34663797 [TBL] [Abstract][Full Text] [Related]
5. PHLPP-mediated dephosphorylation of S6K1 inhibits protein translation and cell growth. Liu J; Stevens PD; Li X; Schmidt MD; Gao T Mol Cell Biol; 2011 Dec; 31(24):4917-27. PubMed ID: 21986499 [TBL] [Abstract][Full Text] [Related]
6. Loss of PHLPP expression in colon cancer: role in proliferation and tumorigenesis. Liu J; Weiss HL; Rychahou P; Jackson LN; Evers BM; Gao T Oncogene; 2009 Feb; 28(7):994-1004. PubMed ID: 19079341 [TBL] [Abstract][Full Text] [Related]
7. Mad1 mediates hypoxia-induced doxorubicin resistance in colon cancer cells by inhibiting mitochondrial function. Cho K; Shin HW; Kim YI; Cho CH; Chun YS; Kim TY; Park JW Free Radic Biol Med; 2013 Jul; 60():201-10. PubMed ID: 23459071 [TBL] [Abstract][Full Text] [Related]
8. c-Myc is regulated by HIF-2α in chronic hypoxia and influences sensitivity to 5-FU in colon cancer. Wang L; Xue M; Chung DC Oncotarget; 2016 Nov; 7(48):78910-78917. PubMed ID: 27793037 [TBL] [Abstract][Full Text] [Related]
9. PHLPP negatively regulates cell motility through inhibition of Akt activity and integrin expression in pancreatic cancer cells. Smith AJ; Wen YA; Stevens PD; Liu J; Wang C; Gao T Oncotarget; 2016 Feb; 7(7):7801-15. PubMed ID: 26760962 [TBL] [Abstract][Full Text] [Related]
10. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways. Rohwer N; Cramer T Drug Resist Updat; 2011 Jun; 14(3):191-201. PubMed ID: 21466972 [TBL] [Abstract][Full Text] [Related]
11. Oncogenic KRAS and BRAF differentially regulate hypoxia-inducible factor-1alpha and -2alpha in colon cancer. Kikuchi H; Pino MS; Zeng M; Shirasawa S; Chung DC Cancer Res; 2009 Nov; 69(21):8499-506. PubMed ID: 19843849 [TBL] [Abstract][Full Text] [Related]
12. Berberine decelerates glucose metabolism via suppression of mTOR‑dependent HIF‑1α protein synthesis in colon cancer cells. Mao L; Chen Q; Gong K; Xu X; Xie Y; Zhang W; Cao H; Hu T; Hong X; Zhan YY Oncol Rep; 2018 May; 39(5):2436-2442. PubMed ID: 29565467 [TBL] [Abstract][Full Text] [Related]
13. The N-terminal region of p27 inhibits HIF-1α protein translation in ribosomal protein S6-dependent manner by regulating PHLPP-Ras-ERK-p90RSK axis. Zhang D; Liu J; Mi X; Liang Y; Li J; Huang C Cell Death Dis; 2014 Nov; 5(11):e1535. PubMed ID: 25412313 [TBL] [Abstract][Full Text] [Related]
14. SNORA74B gene silencing inhibits gallbladder cancer cells by inducing PHLPP and suppressing Akt/mTOR signaling. Qin Y; Meng L; Fu Y; Quan Z; Ma M; Weng M; Zhang Z; Gao C; Shi X; Han K Oncotarget; 2017 Mar; 8(12):19980-19996. PubMed ID: 28212545 [TBL] [Abstract][Full Text] [Related]
15. Imperatorin suppresses proliferation and angiogenesis of human colon cancer cell by targeting HIF-1α via the mTOR/p70S6K/4E-BP1 and MAPK pathways. Mi C; Ma J; Wang KS; Zuo HX; Wang Z; Li MY; Piao LX; Xu GH; Li X; Quan ZS; Jin X J Ethnopharmacol; 2017 May; 203():27-38. PubMed ID: 28341244 [TBL] [Abstract][Full Text] [Related]
16. Pleckstrin Homology (PH) Domain Leucine-rich Repeat Protein Phosphatase Controls Cell Polarity by Negatively Regulating the Activity of Atypical Protein Kinase C. Xiong X; Li X; Wen YA; Gao T J Biol Chem; 2016 Nov; 291(48):25167-25178. PubMed ID: 27760826 [TBL] [Abstract][Full Text] [Related]
17. PHLPPing through history: a decade in the life of PHLPP phosphatases. Grzechnik AT; Newton AC Biochem Soc Trans; 2016 Dec; 44(6):1675-1682. PubMed ID: 27913677 [TBL] [Abstract][Full Text] [Related]
18. Hypoxia-inducible factors modulate the stemness and malignancy of colon cancer cells by playing opposite roles in canonical Wnt signaling. Santoyo-Ramos P; Likhatcheva M; García-Zepeda EA; Castañeda-Patlán MC; Robles-Flores M PLoS One; 2014; 9(11):e112580. PubMed ID: 25396735 [TBL] [Abstract][Full Text] [Related]
19. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway. Gong T; Cui L; Wang H; Wang H; Han N J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734 [TBL] [Abstract][Full Text] [Related]
20. Brusatol inhibits HIF-1 signaling pathway and suppresses glucose uptake under hypoxic conditions in HCT116 cells. Lu Y; Wang B; Shi Q; Wang X; Wang D; Zhu L Sci Rep; 2016 Dec; 6():39123. PubMed ID: 27982118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]